David A. Scott

2.6k total citations · 1 hit paper
50 papers, 1.5k citations indexed

About

David A. Scott is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, David A. Scott has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Organic Chemistry. Recurrent topics in David A. Scott's work include Cancer therapeutics and mechanisms (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Lung Cancer Treatments and Mutations (5 papers). David A. Scott is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Lung Cancer Treatments and Mutations (5 papers). David A. Scott collaborates with scholars based in United States, Australia and South Korea. David A. Scott's co-authors include Nathanael S. Gray, Thomas W. Gero, Pasi A. Jänne, Christoph Gorgulla, Haribabu Arthanari, Yurii S. Moroz, Patrick D. Fischer, Gerhard Wagner, Yehor S. Malets and Paul Coote and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

David A. Scott

47 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An open-source drug discovery platform enables ultra-large virtual screens

2020 395 citations Christoph Gorgulla, Andras Boeszoermenyi et al. Nature profile →

Peers

David A. Scott

ONCOL

CTM

PRM

Campbell McInnes United States

S. Betzi France

Richard A. Norman United Kingdom

Hong Wu China

Klaus Godl Germany

Hao Shao United States

E. Salah United Kingdom

Alison Maloney United Kingdom

Maciej Wieczorek Poland

Shaolong Zhang China

Campbell McInnes United States

David A. Scott

1.2k ×1.2

513 ×1.5

ONCOL

365 ×1.1

CTM

313 ×1.4

116 ×0.7

PRM

Citations per year, relative to David A. Scott David A. Scott (= 1×) peers Campbell McInnes

Countries citing papers authored by David A. Scott

Since Specialization

Citations

This map shows the geographic impact of David A. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Scott more than expected).

Fields of papers citing papers by David A. Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Scott. The network helps show where David A. Scott may publish in the future.

Co-authorship network of co-authors of David A. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Scott. A scholar is included among the top collaborators of David A. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Scott. David A. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hwang, Grace H., Maria F. Pazyra‐Murphy, Hyuk‐Soo Seo, et al.. (2024). A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma. Cancer Research. 84(6). 872–886. 2 indexed citations

Eck, Michael J., David A. Scott, Pasi A. Jänne, et al.. (2023). Abstract LB_C14: EAI-432: A mutant-selective allosteric EGFR inhibitor for L858R-mutant non-small cell lung cancer. Molecular Cancer Therapeutics. 22(12_Supplement). LB_C14–LB_C14. 2 indexed citations

Beyett, Tyler S., Ciric To, David E. Heppner, et al.. (2022). Molecular basis for cooperative binding and synergy of ATP-site and allosteric EGFR inhibitors. Nature Communications. 13(1). 2530–2530. 56 indexed citations

Sewastianik, Tomasz, Hyuk‐Soo Seo, David Remillard, et al.. (2022). A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer. Science Advances. 8(17). eabm3108–eabm3108. 26 indexed citations

Gero, Thomas W., David E. Heppner, Tyler S. Beyett, et al.. (2022). Quinazolinones as allosteric fourth-generation EGFR inhibitors for the treatment of NSCLC. Bioorganic & Medicinal Chemistry Letters. 68. 128718–128718. 13 indexed citations

Shiota, Hitoshi, Artyom A. Alekseyenko, Zhipeng A. Wang, et al.. (2021). Chemical Screen Identifies Diverse and Novel Histone Deacetylase Inhibitors as Repressors of NUT Function: Implications for NUT Carcinoma Pathogenesis and Treatment. Molecular Cancer Research. 19(11). 1818–1830. 13 indexed citations

Mackey, Ashley, Eun Young Choi, Franco A. Rossato, et al.. (2021). Discovery of sterically-hindered phenol compounds with potent cytoprotective activities against ox-LDL–induced retinal pigment epithelial cell death as a potential pharmacotherapy. Free Radical Biology and Medicine. 178. 360–368. 4 indexed citations

Gorgulla, Christoph, Andras Boeszoermenyi, Zifu Wang, et al.. (2020). An open-source drug discovery platform enables ultra-large virtual screens. Nature. 580(7805). 663–668. 395 indexed citations breakdown →

Groendyke, Brian J., Behnam Nabet, Haisheng Zhang, et al.. (2020). Discovery of a Pyrimidothiazolodiazepinone as a Potent and Selective Focal Adhesion Kinase (FAK) Inhibitor. ACS Medicinal Chemistry Letters. 12(1). 30–38. 14 indexed citations

10.

Li, Zhengnian, Chelsea E. Powell, Brian J. Groendyke, et al.. (2020). Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing. Bioorganic & Medicinal Chemistry Letters. 30(19). 127456–127456. 4 indexed citations

11.

Groendyke, Brian J., Chelsea E. Powell, Frédéric Féru, et al.. (2020). Benzopyrimidodiazepinone inhibitors of TNK2. Bioorganic & Medicinal Chemistry Letters. 30(4). 126948–126948. 8 indexed citations

12.

Xiao, Tianshu, Gary Frey, Qingshan Fu, et al.. (2020). HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes. Nature Chemical Biology. 16(5). 529–537. 29 indexed citations

13.

Li, Zhengnian, Benika J. Pinch, Katherine A. Donovan, et al.. (2019). Development and Characterization of a Wee1 Kinase Degrader. Cell chemical biology. 27(1). 57–65.e9. 67 indexed citations

14.

Fontán, Lorena, John M. Hatcher, David A. Scott, et al.. (2019). Chemically Induced Degradation of MALT1 to Treat B-Cell Lymphomas. Blood. 134(Supplement_1). 2073–2073. 5 indexed citations

15.

Scott, David A. & M. J. Denton. (2016). Spinal cord protection in aortic endovascular surgery. British Journal of Anaesthesia. 117. ii26–ii31. 27 indexed citations

16.

Taylor, Polly, Karen Coumbe, Frances Henson, David A. Scott, & A. Taylor. (2013). Evaluation of sedation for standing clinical procedures in horses using detomidine combined with buprenorphine. Veterinary Anaesthesia and Analgesia. 41(1). 14–24. 43 indexed citations

17.

Silbert, Brendan, et al.. (2013). Review of Transcranial Doppler Ultrasound to Detect Microemboli during Orthopedic Surgery. American Journal of Neuroradiology. 35(10). 1858–1863. 10 indexed citations

18.

Scott, David A., Les A. Dakin, David J. Del Valle, et al.. (2013). Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507. Bioorganic & Medicinal Chemistry Letters. 23(16). 4591–4596. 17 indexed citations

19.

Wang, Tao, Stephanos Ioannidis, Lynsie Almeida, et al.. (2011). In vitro and in vivo evaluation of 6-aminopyrazolyl-pyridine-3-carbonitriles as JAK2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(10). 2958–2961. 12 indexed citations

20.

Dhillon, Rana, et al.. (2011). Predictors of creatinine rise post‐endovascular abdominal aortic aneurysm repair. ANZ Journal of Surgery. 81(11). 827–830. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact